-William H Meyer Researcher Activity Profile

Research Author Detailed Information 

William H Meyer Publication Rate By Year

William H Meyer has published 1 paper(s) in 1990, 1 paper(s) in 2004, 7 paper(s) in 2007, 1 paper(s) in 2008, for a total of 10 research publications in total.

William H Wh Meyer Author Information

LAST NAME: meyer

FIRST NAME: William H

INITIALS: wh

AFFILIATION:

Papers

William H Meyer's Publication Record

1. Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: the Children's Oncology Group. Year Published: 2007
Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA. aspappo@txccc.org
2. Correlation between histology and PAX/FKHR fusion status in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group. Year Published: 2007
Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, USA. parhamdavidm@uams.edu
3. Assessment of response to induction therapy and its influence on 5-year failure-free survival in group III rhabdomyosarcoma: the Intergroup Rhabdomyosarcoma Study-IV experience--a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Year Published: 2007
Children's Hospital Cleveland Clinic, Cleveland, USA.
4. Comparison of results of a pilot study of alternating vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide with IRS-IV in intermediate risk rhabdomyosarcoma: a report from the Children's Oncology Group. Year Published: 2007
Mayo Clinic and Foundation, Rochester, Minnesota, USA. carndt@mayo.edu
5. Phosphabicyclononane-containing ru complexes: efficient pre-catalysts for olefin metathesis reactions. Year Published: 2007
6. Comparison of results of a pilot study of alternating vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide with IRS-IV in intermediate risk rhabdomyosarcoma: a report from the Children's Oncology Group. Year Published: 2007
Mayo Clinic and Foundation, Rochester, Minnesota, USA. carndt@mayo.edu
7. DFT prediction and experimental observation of substrate-induced catalyst decomposition in ruthenium-catalyzed olefin metathesis. Year Published: 2004
Sasol Technology (Pty), Ltd., R&D Division, 1 Klasie Havenga Road, Sasolburg 9570, South Africa. werner.jansevanrensburg@sasol.com
8. Phosphabicyclononane-containing ru complexes: efficient pre-catalysts for olefin metathesis reactions. Year Published: 2007
Institute of Chemical Research of Catalonia, Av. Països Catalans, 16, 43007 Tarragona, Spain.
9. Use of MR imaging to assess results of chemotherapy for Ewing sarcoma. Year Published: 1990
Department of Radiology, St. Jude Children's Research Hospital, Memphis, TN 38101-0318.
10. Periosteal osteosarcoma in the hand of a pediatric patient: a case report. Year Published: 2008
Department of Orthopedic Surgery & Rehabilitation, University of Oklahoma, Oklahoma City, OK 73117-1026, USA.